MIST: Riding the Market Waves of Growth and Decline in 2023

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 26.35%.However, over the last six months, we can see a stronger performance of -27.24%. Over the last 30 days, the price of MIST has fallen by 34.39%. And in the last five days, it has surged by 37.91%.

Milestone Pharmaceuticals Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $4.49 on 05/12/23 and the lowest value was $1.33 on 01/22/24.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


52-week price history of MIST Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Milestone Pharmaceuticals Inc’s current trading price is -53.01% away from its 52-week high, while its distance from the 52-week low is 58.65%. The stock’s price range during this period has varied between$1.33 and $4.49. The Milestone Pharmaceuticals Inc’s shares, which operate in the Healthcare, saw a trading volume of around 3.2 million for the day, a figure considerably higher than their average daily volume of 0.28 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Milestone Pharmaceuticals Inc (MIST) has experienced a quarterly decline of -20.38% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 70.64M and boasts a workforce of 39 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.3000, with a change in price of -0.8700. Similarly, Milestone Pharmaceuticals Inc recorded 246,737 in trading volume during the last 100 days, posting a change of -29.19%.

MIST’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MIST stands at 1.79. Similarly, the long-term debt-to-equity ratio is also 1.77.

MIST Stock Stochastic Average

Milestone Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 48.75%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 69.79%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 72.15% and 59.61%, respectively.

On Key

Related Posts